Picture of Nemaura Medical logo

NMRD — Nemaura Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Nemaura Medical Inc reports results for the quarter ended in June - Earnings Summary

* Nemaura Medical Inc  NMRD.OQ  reported a quarterly
adjusted loss
of 17 cents​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 17 cents per share.
    * Reported revenue was zero​; analysts expected $450.00
thousand. 
    * Nemaura Medical Inc's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts had fallen by
about 21.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Nemaura Medical Inc shares had fallen by 7.8% this
quarter and
lost 48.0% so far this year.
    * The company reported a quarterly loss of $3.98 million.
    * Wall Street's median 12-month price target for Nemaura
Medical
Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.17          -0.17          Met
 Mar. 31 2022      -0.14          -0.15          Missed
 Dec. 31 2021      -0.14          -0.15          Missed
 Sep. 30 2021      -0.11          -0.15          Missed

Recent news on Nemaura Medical

See all news